BioWorld

March 15, 2010

View Archived Issues

Novel Research Links Rare Disease to Even Rarer One

Read More

Micromet Gears for Pivotal Trial Raising $70M in Stock Offering

Read More

Drug Safety Challenges Persist, Despite New FDA Clout, Funds

Read More

Stock Movers

Read More

Other News To Note

Read More

Clinic Roundup

Read More

AVEO Squeezes $81M Out of IPO Window; No Fools Rush in

AVEO Pharmaceuticals Inc. pushed its way out the initial public offering window Thursday night, raising $81 million through the sale of 9 million shares for $9 apiece. (BioWorld Today) Read More

Bench Press

Read More

Late-Stage Cancer Misses Could Mean Advantage for Competitors

Read More